See more : Cinedigm Corp. (CIDM) Income Statement Analysis – Financial Results
Complete financial analysis of Fortrea Holdings Inc. (FTRE) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Fortrea Holdings Inc., a leading company in the Biotechnology industry within the Healthcare sector.
- Alwaha REIT Fund (9300.SR) Income Statement Analysis – Financial Results
- Redox Limited (RDX.AX) Income Statement Analysis – Financial Results
- PT Merck Tbk (MERK.JK) Income Statement Analysis – Financial Results
- Tevano Systems Holdings Inc. (TEVO.CN) Income Statement Analysis – Financial Results
- Nippon Chemi-Con Corporation (6997.T) Income Statement Analysis – Financial Results
Fortrea Holdings Inc. (FTRE)
About Fortrea Holdings Inc.
Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. It operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is based in Durham, North Carolina.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 3.11B | 3.10B | 3.06B | 2.58B |
| Cost of Revenue | 2.69B | 2.47B | 2.45B | 2.09B |
| Gross Profit | 424.00M | 621.70M | 604.40M | 489.10M |
| Gross Profit Ratio | 13.64% | 20.08% | 19.77% | 18.96% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 336.60M | 299.90M | 303.10M | 267.60M |
| Other Expenses | 0.00 | 7.00M | 1.90M | 800.00K |
| Operating Expenses | 457.30M | 396.20M | 469.40M | 386.60M |
| Cost & Expenses | 3.05B | 2.87B | 2.92B | 2.48B |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 69.80M | 132.40M | 200.00K | 0.00 |
| Depreciation & Amortization | 96.40M | 117.60M | 198.80M | 156.40M |
| EBITDA | 166.90M | 354.60M | 335.20M | -175.80M |
| EBITDA Ratio | 5.37% | 10.62% | 9.87% | 25.46% |
| Operating Income | 63.10M | 185.20M | 114.30M | -314.20M |
| Operating Income Ratio | 2.03% | 5.98% | 3.74% | -12.18% |
| Total Other Income/Expenses | -62.00M | 1.10M | 22.10M | -434.70M |
| Income Before Tax | 1.10M | 58.90M | 136.40M | -332.20M |
| Income Before Tax Ratio | 0.04% | 1.90% | 4.46% | -12.87% |
| Income Tax Expense | 4.50M | 500.00K | 38.40M | 27.00M |
| Net Income | -3.40M | 58.40M | 98.00M | -359.20M |
| Net Income Ratio | -0.11% | 1.89% | 3.21% | -13.92% |
| EPS | -0.04 | 0.66 | 1.11 | -4.06 |
| EPS Diluted | -0.04 | 0.64 | 1.11 | -4.06 |
| Weighted Avg Shares Out | 88.80M | 88.40M | 88.40M | 88.40M |
| Weighted Avg Shares Out (Dil) | 88.80M | 91.10M | 88.40M | 88.40M |
ATTENTION Fortrea Holdings Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortrea Holdings Inc. - FTRE
An Investigation Has Commenced on Behalf of Fortrea Holdings Inc. Shareholders. Contact Levi & Korsinsky to Discuss your FTRE Losses
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortrea Holdings Inc. - FTRE
Fortrea Holdings Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - FTRE
Bronstein, Gewirtz & Grossman, LLC Encourages Fortrea Holdings Inc. (FTRE) Shareholders to Inquire about Securities Investigation
Levi & Korsinsky Reminds Fortrea Holdings Inc. Investors of the Ongoing Investigation into Potential Violations of Securities Laws - FTRE
Bronstein, Gewirtz & Grossman, LLC Is Investigating Fortrea Holdings Inc. (FTRE) And Encourages Shareholders to Connect
Investors who lost money on Fortrea Holdings Inc. should contact Levi & Korsinsky about an ongoing investigation - FTRE
FTRE INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Fortrea Holdings Inc. and Encourages Investors to Contact the Firm
Source: https://incomestatements.info
Category: Stock Reports